1. Home
  2. OGN vs CNXC Comparison

OGN vs CNXC Comparison

Compare OGN & CNXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.43

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Concentrix Corporation

CNXC

Concentrix Corporation

BUY

Current Price

$24.67

Market Cap

1.7B

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
OGN
CNXC
Founded
1923
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
OGN
CNXC
Price
$13.43
$24.67
Analyst Decision
Hold
Strong Buy
Analyst Count
5
5
Target Price
$11.40
$54.80
AVG Volume (30 Days)
2.6M
1.3M
Earning Date
05-07-2026
03-24-2026
Dividend Yield
0.60%
5.79%
EPS Growth
N/A
N/A
EPS
0.55
0.33
Revenue
$6,216,000,000.00
$9,825,771,000.00
Revenue This Year
$0.45
$5.29
Revenue Next Year
$1.67
$2.49
P/E Ratio
$24.42
$75.91
Revenue Growth
N/A
2.15
52 Week Low
$5.69
$22.05
52 Week High
$13.49
$62.14

Technical Indicators

Market Signals
Indicator
OGN
CNXC
Relative Strength Index (RSI) 72.03 42.49
Support Level $10.05 $24.93
Resistance Level $13.46 $34.64
Average True Range (ATR) 0.05 1.62
MACD -0.11 -0.25
Stochastic Oscillator 57.14 20.88

Price Performance

Historical Comparison
OGN
CNXC

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About CNXC Concentrix Corporation

Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.

Share on Social Networks: